Literature DB >> 9271797

DNA complex lesions induced by protons and alpha-particles: track structure characteristics determining linear energy transfer and particle type dependence.

A Ottolenghi1, M Merzagora, H G Paretzke.   

Abstract

The yield of DNA double-strand breaks (dsb) and DNA complex lesions induced by protons and alpha-particles of various energies was simulated using a Monte Carlo track structure code (MOCA15) and a simple model of the DNA molecule. DNA breaks of different complexity were analysed. The linear energy transfer (LET) and particle-type dependence of lesions of higher complexity seems to confirm the importance of clustered damage in DNA as a relevant step leading to biological endpoints such as cell inactivation. The detailed structure of proton and alpha-particle tracks was analysed to identify the main characteristics possibly responsible for such a dependence. The role of the primary ion and of its secondary electrons in inducing dsb and complex lesions is described, showing that the relative contribution of secondary electron tracks alone in inducing clustered lesions is almost negligible at high LET, but tends to dominate below = 10 keV/micron. This is consistent with the observed similar effectiveness of low-LET fast particle radiation and sparsely ionizing radiation such as x-rays. The dependence on LET and particle type is mainly due to energy deposition events of the primary ion together with short range electrons surrounding the ion track; the yield of complex lesions due to secondary electron tracks alone is substantially LET independent. The radial distributions of the energy contributing to the induction of complex lesions were analyzed and compared with the radial distributions of energy deposition of the full tracks. The results suggest that the stochastic behaviour (i.e. cluster properties) of the energy deposition pattern within a radius of a few nanometers around the ion track plays a relevant role in determining the biological radiation effectiveness.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9271797     DOI: 10.1007/s004110050060

Source DB:  PubMed          Journal:  Radiat Environ Biophys        ISSN: 0301-634X            Impact factor:   1.925


  6 in total

Review 1.  Health risks of space exploration: targeted and nontargeted oxidative injury by high-charge and high-energy particles.

Authors:  Min Li; Géraldine Gonon; Manuela Buonanno; Narongchai Autsavapromporn; Sonia M de Toledo; Debkumar Pain; Edouard I Azzam
Journal:  Antioxid Redox Signal       Date:  2013-12-06       Impact factor: 8.401

2.  Radiation-generated short DNA fragments may perturb non-homologous end-joining and induce genomic instability.

Authors:  Dalong Pang; Thomas A Winters; Mira Jung; Shubhadeep Purkayastha; Luciane R Cavalli; Sergey Chasovkikh; Bassem R Haddad; Anatoly Dritschilo
Journal:  J Radiat Res       Date:  2011       Impact factor: 2.724

3.  The effect of energy spectrum change on DNA damage in and out of field in 10-MV clinical photon beams.

Authors:  A O Ezzati; Y Xiao; M Sohrabpour; M T Studenski
Journal:  Med Biol Eng Comput       Date:  2014-10-29       Impact factor: 2.602

Review 4.  Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury.

Authors:  Edouard I Azzam; Jean-Paul Jay-Gerin; Debkumar Pain
Journal:  Cancer Lett       Date:  2011-12-17       Impact factor: 8.679

5.  Comparative gene expression analysis after exposure to 123I-iododeoxyuridine, γ- and α-radiation-potential biomarkers for the discrimination of radiation qualities.

Authors:  Marcus Unverricht-Yeboah; Ulrich Giesen; Ralf Kriehuber
Journal:  J Radiat Res       Date:  2018-07-01       Impact factor: 2.724

Review 6.  Adverse outcome pathways for ionizing radiation and breast cancer involve direct and indirect DNA damage, oxidative stress, inflammation, genomic instability, and interaction with hormonal regulation of the breast.

Authors:  Jessica S Helm; Ruthann A Rudel
Journal:  Arch Toxicol       Date:  2020-05-13       Impact factor: 5.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.